EMEA-002194-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Opicinumab

Decision numberP/0369/2017
PIP numberEMEA-002194-PIP01-17
Pharmaceutical form(s)Solution for injection/infusion
Condition(s)/indication(s)

Treatment of multiple sclerosis

Route(s) of administrationIntravenous use
PIP applicant

Biogen Idec Limited
Tel. +44 1628512586
E-mail: pip.enquiries@biogen.com

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision